Using machine learning to predict early readmission following esophagectomy.


Journal

The Journal of thoracic and cardiovascular surgery
ISSN: 1097-685X
Titre abrégé: J Thorac Cardiovasc Surg
Pays: United States
ID NLM: 0376343

Informations de publication

Date de publication:
06 2021
Historique:
received: 07 11 2019
revised: 17 04 2020
accepted: 30 04 2020
pubmed: 28 7 2020
medline: 13 7 2021
entrez: 27 7 2020
Statut: ppublish

Résumé

To establish a machine learning (ML)-based prediction model for readmission within 30 days (early readmission or early readmission) of patients based on their profile at index hospitalization for esophagectomy. Using the National Readmission Database, 383 patients requiring early readmission out of a total of 2037 esophagectomy patients alive at discharge in 2016 were identified. Early readmission risk factors were identified using standard statistics and after the application of ML methodology, the models were interpreted. Early readmission after esophagectomy connoted an increased severity score and risk of mortality. Chronic obstructive pulmonary disease and malnutrition as well as postoperative prolonged intubation, pneumonia, acute kidney failure, and length of stay were identified as factors most contributing to increased odds of early readmission. The reasons for early readmission were more likely to be cardiopulmonary complications, anastomotic leak, and sepsis/infection. Patients with upper esophageal neoplasms had significantly higher early readmission and patients who received pyloroplasty/pyloromyotomy had significantly lower early readmission. Two ML models to predict early readmission were generated: 1 with 71.7% sensitivity for clinical decision making and the other with 84.8% accuracy and 98.7% specificity for quality review. We identified risk factors for early readmission after esophagectomy and introduced ML-based techniques to predict early readmission in 2 different settings: clinical decision making and quality review. ML techniques can be utilized to provide targeted support and standardize quality measures.

Identifiants

pubmed: 32711985
pii: S0022-5223(20)31267-8
doi: 10.1016/j.jtcvs.2020.04.172
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1926-1939.e8

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : CommentIn
Type : ExpressionOfConcernIn
Type : ErratumIn

Informations de copyright

Copyright © 2020 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Siavash Bolourani (S)

The Feinstein Institutes for Medical Research, Manhasset, NY; Elmezzi Graduate School of Molecular Medicine, Manhasset, NY; Department of Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY; Department of Cardiovascular and Thoracic Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY.

Mohammad A Tayebi (MA)

School of Computing Science, Simon Fraser University, Burnaby, British Columbia, Canada.

Li Diao (L)

The Feinstein Institutes for Medical Research, Manhasset, NY.

Ping Wang (P)

The Feinstein Institutes for Medical Research, Manhasset, NY; Elmezzi Graduate School of Molecular Medicine, Manhasset, NY; Department of Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY.

Vihas Patel (V)

Department of Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY.

Frank Manetta (F)

Department of Cardiovascular and Thoracic Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY.

Paul C Lee (PC)

Department of Cardiovascular and Thoracic Surgery, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Manhasset, NY. Electronic address: plee15@northwell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH